(HRB) H&R Block - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0936711052
Stock:
Total Rating 40
Risk 79
Buy Signal 0.28
| Risk 5d forecast | |
|---|---|
| Volatility | 37.7% |
| Relative Tail Risk | -0.87% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.53 |
| Alpha | -47.06 |
| Character TTM | |
|---|---|
| Beta | 0.228 |
| Beta Downside | -0.694 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.54% |
| CAGR/Max DD | -0.03 |
EPS (Earnings per Share)
Revenue
Description: HRB H&R Block
H&R Block, Inc., through its subsidiaries, provides assisted and do-it-yourself (DIY) tax return preparation services in the United States, Canada, and Australia. The company also provides Refund Transfers, that enable clients to receive their tax refunds by their chosen method of disbursement; Peace of Mind extended service plans, that represents clients when audited and assumes the cost; H&R Block Emerald Prepaid Mastercard and Spruce, which are debit cards that can be used for everyday purchases and ATM withdrawals; H&R Block Emerald Advance term loans; Tax Identity Shield that provides clients assistance in helping protect their tax identity and access to services to help restore their tax identity; refund advance loans; and H&R Block Instant Refund. In addition, it offers small business financial solutions to manage finances, including payment processing, payroll, and bookkeeping services. The company its solutions through in-person; a system of retail offices operated directly by the company or its franchisees; and online and mobile applications, virtual, and desktop software. H&R Block, Inc. was incorporated in 1955 and is headquartered in Kansas City, Missouri.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 613.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA -7.45 > 1.0 |
| NWC/Revenue: 4.93% < 20% (prev -7.79%; Δ 12.72% < -1%) |
| CFO/TA 0.21 > 3% & CFO 605.7m > Net Income 613.8m |
| Net Debt (2.87b) to EBITDA (989.4m): 2.90 < 3 |
| Current Ratio: 1.29 > 1.5 & < 3 |
| Outstanding Shares: last quarter (126.6m) vs 12m ago -6.64% < -2% |
| Gross Margin: 54.68% > 18% (prev 0.44%; Δ 5423 % > 0.5%) |
| Asset Turnover: 134.4% > 50% (prev 133.5%; Δ 0.88% > 0%) |
| Interest Coverage Ratio: 10.72 > 6 (EBITDA TTM 989.4m / Interest Expense TTM 81.3m) |
Altman Z'' 1.22
| A: 0.06 (Total Current Assets 841.8m - Total Current Liabilities 654.8m) / Total Assets 2.93b |
| B: -0.31 (Retained Earnings -904.8m / Total Assets 2.93b) |
| C: 0.31 (EBIT TTM 871.7m / Avg Total Assets 2.82b) |
| D: -0.25 (Book Value of Equity -954.6m / Total Liabilities 3.75b) |
| Altman-Z'' Score: 1.22 = BB |
Beneish M -2.88
| DSRI: 1.05 (Receivables 352.5m/321.2m, Revenue 3.79b/3.62b) |
| GMI: 0.81 (GM 54.68% / 44.31%) |
| AQI: 1.41 (AQ_t 0.71 / AQ_t-1 0.51) |
| SGI: 1.05 (Revenue 3.79b / 3.62b) |
| TATA: 0.00 (NI 613.8m - CFO 605.7m) / TA 2.93b) |
| Beneish M-Score: -2.88 (Cap -4..+1) = A |
What is the price of HRB shares?
As of February 27, 2026, the stock is trading at USD 31.49 with a total of 2,183,137 shares traded.
Over the past week, the price has changed by +2.14%, over one month by -22.57%, over three months by -23.77% and over the past year by -39.56%.
Over the past week, the price has changed by +2.14%, over one month by -22.57%, over three months by -23.77% and over the past year by -39.56%.
Is HRB a buy, sell or hold?
H&R Block has received a consensus analysts rating of 3.00.
Therefor, it is recommend to hold HRB.
- StrongBuy: 0
- Buy: 1
- Hold: 2
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the HRB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 41 | 30.2% |
| Analysts Target Price | 41 | 30.2% |
HRB Fundamental Data Overview February 21, 2026
P/E Trailing = 7.3933
P/E Forward = 5.787
P/S = 1.031
P/B = 73.5597
P/EG = 0.463
Revenue TTM = 3.79b USD
EBIT TTM = 871.7m USD
EBITDA TTM = 989.4m USD
Long Term Debt = 2.44b USD (from longTermDebt, last quarter)
Short Term Debt = 200.7m USD (from shortTermDebt, last quarter)
Debt = 3.23b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.87b USD (from netDebt column, last quarter)
Enterprise Value = 6.79b USD (3.91b + Debt 3.23b - CCE 349.2m)
Interest Coverage Ratio = 10.72 (Ebit TTM 871.7m / Interest Expense TTM 81.3m)
EV/FCF = 12.96x (Enterprise Value 6.79b / FCF TTM 524.1m)
FCF Yield = 7.72% (FCF TTM 524.1m / Enterprise Value 6.79b)
FCF Margin = 13.83% (FCF TTM 524.1m / Revenue TTM 3.79b)
Net Margin = 16.19% (Net Income TTM 613.8m / Revenue TTM 3.79b)
Gross Margin = 54.68% ((Revenue TTM 3.79b - Cost of Revenue TTM 1.72b) / Revenue TTM)
Gross Margin QoQ = 84.91% (prev 8.79%)
Tobins Q-Ratio = 2.32 (Enterprise Value 6.79b / Total Assets 2.93b)
Interest Expense / Debt = 0.72% (Interest Expense 23.4m / Debt 3.23b)
Taxrate = 22.01% (172.0m / 781.4m)
NOPAT = 679.9m (EBIT 871.7m * (1 - 22.01%))
Current Ratio = 1.29 (Total Current Assets 841.8m / Total Current Liabilities 654.8m)
Debt / Equity = -3.93 (negative equity) (Debt 3.23b / totalStockholderEquity, last quarter -823.1m)
Debt / EBITDA = 2.90 (Net Debt 2.87b / EBITDA 989.4m)
Debt / FCF = 5.47 (Net Debt 2.87b / FCF TTM 524.1m)
Total Stockholder Equity = -369.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 21.76% (Net Income 613.8m / Total Assets 2.93b)
RoE = -166.1% (negative equity) (Net Income TTM 613.8m / Total Stockholder Equity -369.5m)
RoCE = 42.19% (EBIT 871.7m / Capital Employed (Equity -369.5m + L.T.Debt 2.44b))
RoIC = 47.89% (NOPAT 679.9m / Invested Capital 1.42b)
WACC = 3.95% (E(3.91b)/V(7.14b) * Re(6.76%) + D(3.23b)/V(7.14b) * Rd(0.72%) * (1-Tc(0.22)))
Discount Rate = 6.76% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -5.71%
[DCF] Terminal Value 85.45% ; FCFF base≈589.4m ; Y1≈541.8m ; Y5≈484.9m
[DCF] Fair Price = 92.67 (EV 14.61b - Net Debt 2.87b = Equity 11.75b / Shares 126.8m; r=5.90% [WACC]; 5y FCF grow -10.12% → 2.90% )
EPS Correlation: -21.94 | EPS CAGR: -61.05% | SUE: -0.03 | # QB: 0
Revenue Correlation: -18.88 | Revenue CAGR: -46.40% | SUE: 0.60 | # QB: 0
EPS next Quarter (2026-03-31): EPS=5.77 | Chg7d=+0.022 | Chg30d=+0.022 | Revisions Net=+0 | Analysts=4
EPS current Year (2026-06-30): EPS=5.00 | Chg7d=+0.050 | Chg30d=+0.050 | Revisions Net=+2 | Growth EPS=+7.3% | Growth Revenue=+3.4%
EPS next Year (2027-06-30): EPS=5.58 | Chg7d=+0.110 | Chg30d=+0.110 | Revisions Net=+2 | Growth EPS=+11.6% | Growth Revenue=+3.2%
[Analyst] Revisions Ratio: +0.00 (2 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -5.6% (Discount Rate 7.9% - Earnings Yield 13.5%)
[Growth] Growth Spread = +8.1% (Analyst 2.6% - Implied -5.6%)
P/E Forward = 5.787
P/S = 1.031
P/B = 73.5597
P/EG = 0.463
Revenue TTM = 3.79b USD
EBIT TTM = 871.7m USD
EBITDA TTM = 989.4m USD
Long Term Debt = 2.44b USD (from longTermDebt, last quarter)
Short Term Debt = 200.7m USD (from shortTermDebt, last quarter)
Debt = 3.23b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.87b USD (from netDebt column, last quarter)
Enterprise Value = 6.79b USD (3.91b + Debt 3.23b - CCE 349.2m)
Interest Coverage Ratio = 10.72 (Ebit TTM 871.7m / Interest Expense TTM 81.3m)
EV/FCF = 12.96x (Enterprise Value 6.79b / FCF TTM 524.1m)
FCF Yield = 7.72% (FCF TTM 524.1m / Enterprise Value 6.79b)
FCF Margin = 13.83% (FCF TTM 524.1m / Revenue TTM 3.79b)
Net Margin = 16.19% (Net Income TTM 613.8m / Revenue TTM 3.79b)
Gross Margin = 54.68% ((Revenue TTM 3.79b - Cost of Revenue TTM 1.72b) / Revenue TTM)
Gross Margin QoQ = 84.91% (prev 8.79%)
Tobins Q-Ratio = 2.32 (Enterprise Value 6.79b / Total Assets 2.93b)
Interest Expense / Debt = 0.72% (Interest Expense 23.4m / Debt 3.23b)
Taxrate = 22.01% (172.0m / 781.4m)
NOPAT = 679.9m (EBIT 871.7m * (1 - 22.01%))
Current Ratio = 1.29 (Total Current Assets 841.8m / Total Current Liabilities 654.8m)
Debt / Equity = -3.93 (negative equity) (Debt 3.23b / totalStockholderEquity, last quarter -823.1m)
Debt / EBITDA = 2.90 (Net Debt 2.87b / EBITDA 989.4m)
Debt / FCF = 5.47 (Net Debt 2.87b / FCF TTM 524.1m)
Total Stockholder Equity = -369.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 21.76% (Net Income 613.8m / Total Assets 2.93b)
RoE = -166.1% (negative equity) (Net Income TTM 613.8m / Total Stockholder Equity -369.5m)
RoCE = 42.19% (EBIT 871.7m / Capital Employed (Equity -369.5m + L.T.Debt 2.44b))
RoIC = 47.89% (NOPAT 679.9m / Invested Capital 1.42b)
WACC = 3.95% (E(3.91b)/V(7.14b) * Re(6.76%) + D(3.23b)/V(7.14b) * Rd(0.72%) * (1-Tc(0.22)))
Discount Rate = 6.76% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -5.71%
[DCF] Terminal Value 85.45% ; FCFF base≈589.4m ; Y1≈541.8m ; Y5≈484.9m
[DCF] Fair Price = 92.67 (EV 14.61b - Net Debt 2.87b = Equity 11.75b / Shares 126.8m; r=5.90% [WACC]; 5y FCF grow -10.12% → 2.90% )
EPS Correlation: -21.94 | EPS CAGR: -61.05% | SUE: -0.03 | # QB: 0
Revenue Correlation: -18.88 | Revenue CAGR: -46.40% | SUE: 0.60 | # QB: 0
EPS next Quarter (2026-03-31): EPS=5.77 | Chg7d=+0.022 | Chg30d=+0.022 | Revisions Net=+0 | Analysts=4
EPS current Year (2026-06-30): EPS=5.00 | Chg7d=+0.050 | Chg30d=+0.050 | Revisions Net=+2 | Growth EPS=+7.3% | Growth Revenue=+3.4%
EPS next Year (2027-06-30): EPS=5.58 | Chg7d=+0.110 | Chg30d=+0.110 | Revisions Net=+2 | Growth EPS=+11.6% | Growth Revenue=+3.2%
[Analyst] Revisions Ratio: +0.00 (2 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -5.6% (Discount Rate 7.9% - Earnings Yield 13.5%)
[Growth] Growth Spread = +8.1% (Analyst 2.6% - Implied -5.6%)